Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Completion Rate
    0%(0/2)
    Active Trials
    0(0%)
    Terminated
    2(100%)

    Phase Distribution

    Not Applicable
    1
    50%

    Phase Distribution

    0

    Early Stage

    0

    Mid Stage

    0

    Late Stage

    Phase Distribution1 total trials
    N/ANon-phased studies
    1(100.0%)

    Highest Phase Reached

    Unknown

    Trial Status & Enrollment

    Completion Rate

    0.0%

    0 of 2 finished

    Non-Completion Rate

    100.0%

    2 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    2

    all time

    Status Distribution
    Terminated(2)

    Detailed Status

    Terminated2

    Development Timeline

    Analytics

    Development Status

    Total Trials
    2
    Active
    0
    Success Rate
    0.0%
    Most Advanced
    N/A

    Trials by Phase

    N/A1 (100.0%)

    Trials by Status

    terminated2100%

    Recent Activity

    0 active trials
    Showing 2 of 2
    terminatednot_applicable

    Safety of Optimal PEEP in NSICU Patients

    NCT03862027
    terminated

    ARDS Esophageal Balloon Pressure Changes With Positioning Study

    NCT03120793

    Clinical Trials (2)

    Showing 2 of 2 trials
    NCT03862027Not Applicable

    Safety of Optimal PEEP in NSICU Patients

    Terminated
    NCT03120793

    ARDS Esophageal Balloon Pressure Changes With Positioning Study

    Terminated

    All 2 trials loaded

    Drug Details

    Intervention Type
    Device
    Total Trials
    2